CliffBio
biologic

Biothrax

Anthrax Vaccine Adsorbed

Loss of exclusivityNovember 2010projected — 12-year biologic exclusivity estimate
CompanyEmergent BioDefense Operations Lansing LLC

Drug detail

Brand nameBiothrax
Active ingredientAnthrax Vaccine Adsorbed
Strength0.5ML
Dosage formInjection
RouteSubcutaneous
ModalityBiologic
FDA approvalNovember 1998
Marketing statusRx

More from Emergent BioDefense Operations Lansing LLC

Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.